Asthma Journal Articles

• MIS in Children After SARS-CoV-2 Vaccination Does COVID-19 vaccination play a role in the pathogenesis of multisystem inflammatory syndrome in children? This report helps further our understanding.
  Emerging Infectious Diseases, May 20, 2022
• Waning Effectiveness of mRNA Vaccines Against COVID-19 The findings in this report underscore the importance of receiving a third dose of mRNA COVID-19 vaccine and suggest that an additional dose may be necessary to sustain protection.
  Morbidity & Mortality Weekly Report, May 13, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Outcomes Among Adults With SARS-CoV-2 Infection Delta/Omicron This CDC report reaffirms that COVID-19 vaccination, particularly a booster dose, continues to be critical in mitigating the health care burden of the Omicron variant.
  Morbidity & Mortality Weekly Report, May 09, 2022
• Sedation for Patients Undergoing ERCP This study looked at two different propofol regimens for sedation in patients undergoing endoscopic retrograde cholangiopancreatography. Which has a better safety profile?
  BMC Anesthesiology, May 09, 2022
• Rheumatoid Factor Positivity in ANCA-Associated Vasculitis What is the role of rheumatoid factor positivity in ANCA-associated vasculitis? A new study investigates.
  Rheumatology, May 04, 2022
• Therapies for Episodic and Chronic Cluster Headache Review the current options for acute and preventive treatments for cluster headache. How might network meta-analyses be used to compare these treatments?
  Headache, April 29, 2022
• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19 Receipt of a third mRNA vaccine dose was highly effective at preventing moderately severe and severe COVID-19 during Delta and Omicron predominance, according to this report.
  Morbidity & Mortality Weekly Report, April 25, 2022
• Determinants, Trends of COVID-19 Vaccine Hesitancy and Uptake This study examined sociodemographic and behavioral factors as well as COVID-related risk perceptions which contribute to vaccine hesitancy in U.S. adults.
  American Journal of Epidemiology, April 21, 2022
• Vascular Thrombosis in Severe COVID-19 Requiring ECMO How prevalent are vascular thromboses among severe COVID-19 patients who received ECMO?
  Critical Care Medicine, April 13, 2022
• Tralokinumab Plus Topical Corticosteroids in Severe AD This study evaluated the efficacy and safety of tralokinumab plus topical corticosteroids in adult patients with severe AD whose disease was not adequately controlled with ciclosporin A.
  The British Journal of Dermatology, April 11, 2022
• Effectiveness of Pfizer mRNA Vaccine Against MIS-C Receipt of 2 doses of the Pfizer-BioNTech vaccine is associated with a high level of protection against multisystem inflammatory syndrome in children aged 12 to 18 years, according to this CDC report.
  Morbidity & Mortality Weekly Report, April 04, 2022
• Conjunctivitis in Moderate-to-severe Atopic Dermatitis Are patients receiving tralokinumab for moderate-to-severe atopic dermatitis at increased risk of developing conjunctivitis?
  The British Journal of Dermatology, April 04, 2022
• SARS-CoV-2 Period Seroprevalence and Related Factors A study of SARS-CoV-2 seroprevalence among residents of one county helps determine the various factors associated with SARS-CoV-2 antibodies.
  Emerging Infectious Diseases, March 31, 2022
• Outcomes in Those Aged <18 Years Hospitalized With COVID-19 Many pediatric patients in this study with COVID-19-related hospitalization had severe illness and viral coinfections, and few had been vaccinated, according to this CDC report.
  Morbidity & Mortality Weekly Report, March 21, 2022
• Pfizer Vaccine Effectiveness Among Adolescents 12-17 This report found that full vaccination with 2 doses of Pfizer-BioNTech vaccine was 92% effective against confirmed SARS-CoV-2 infection in adolescents aged 12-17.
  Morbidity & Mortality Weekly Report, March 18, 2022
• COVID-19 and Pediatric Asthma: Friend or Foe? What do we currently know about the interplay between COVID-19 and asthma in children?
  Current Opinion in Allergy and Clinical Immunology, March 17, 2022
• E-Cigarettes and Cardiopulmonary Health This review summarizes what we currently know about the impact of e-cigarettes and vaping on cardiopulmonary health, but there are many unanswered questions.
  Circulation, March 14, 2022
• Impact of Time to Intubation in COVID-19 Patients A new study evaluates the potential impacts of early versus delayed mechanical ventilation initiation among critically ill COVID-19 patients. What is the optimal timing?
  Critical Care, March 11, 2022